
Ligand Pharmaceuticals Incorporated (LGND)
US$ 113.51-5.69%
Price Chart
Key Statistics
Market Cap
$ 2.02B
P/E Ratio
0.00
Revenue (TTM)
$ 181.49M
Volume
104.55K
52W High
$ 129.90
52W Low
$ 77.43
Dividend Yield
0.00%
Beta
0.76
Technicals
50-Day MA
106.08
200-Day MA
109.4536
52 Week High
129.9
52 Week Low
77.43
About LGND
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFiv.
Employees
68
Headquarters
Jupiter, FL
CEO
Mr. Todd C. Davis Ph.D.
Latest News
CEO & Director of Ligand Pharmaceuticals Todd Davis Buys 9.2% More Shares - simplywall.st
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg